Target Price | ¥1,632.00 |
Price | ¥1,697.00 |
Deviation |
3.83%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Ono Pharmaceutical 2026 .
The average Ono Pharmaceutical target price is ¥1,632.00.
This is
3.83%
register free of charge
¥1,890.00
11.37%
register free of charge
¥1,414.00
16.68%
register free of charge
|
|
A rating was issued by 18 analysts: 0 Analysts recommend Ono Pharmaceutical to buy, 9 to hold and 9 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Ono Pharmaceutical stock has an average upside potential 2026 of
3.83%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion ¥ | 486.87 | 503.48 |
3.14% | 3.41% | |
EBITDA Margin | 13.33% | 24.79% |
58.87% | 85.96% | |
Net Margin | 10.28% | 13.88% |
59.62% | 35.03% |
12 Analysts have issued a sales forecast Ono Pharmaceutical 2026 . The average Ono Pharmaceutical sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Ono Pharmaceutical EBITDA forecast 2026. The average Ono Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Ono Pharmaceutical Analysts have issued a net profit forecast 2026. The average Ono Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share ¥ | 106.53 | 148.74 |
60.04% | 39.62% | |
P/E | 11.41 | |
EV/Sales | 1.58 |
12 Analysts have issued a Ono Pharmaceutical forecast for earnings per share. The average Ono Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Ono Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.